Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Melonfrost logo — The Bioreactor Company

Melonfrost

The Bioreactor Company

Founded 2019 United States Brooklyn, United States 3 employees Seed Total: $13.00M AI, Biotechnology +2

General Information

Company Name Melonfrost
Founded Year 2019
Location United States Brooklyn, United States
Employees 3
Industries AI, Biotechnology, Manufacturing +1
Funding Stage Seed
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Service Fee, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Melonfrost. To contact Melonfrost, visit melonfrost.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Melonfrost compare?

A PDF of Melonfrost and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Melonfrost soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Melonfrost

Melonfrost, known as The Bioreactor Company, was founded in 2019 with the mission of streamlining biomanufacturing research and development. Operating at the intersection of AI, Biotechnology, Manufacturing, and Robotics, this innovative company is headquartered in the United States.

With a recent $7.00M seed round investment secured on 25 January 2023, Melonfrost has attracted the attention of notable investors such as Refactor Capital and Alexandria Venture Investments. This financial backing underscores confidence in Melonfrost's potential to disrupt the biomanufacturing industry through advanced technological integration.

As an emerging leader in bioreactor technology, Melonfrost offers significant growth potential for investors seeking opportunities in cutting-edge biotech applications. Its focus on R&D optimization positions the company as a compelling candidate for further investment in the biomanufacturing sector.

Business keywords: biomanufacturing, bioreactors, bioproduct development, R&D streamlining, biotechnological innovations, bioprocess optimization, biotechnical equipment, biomanufacturing efficiency, biotechnology advancements, custom bioreactor design, bioprocess engineering, industrial biotechnology

Services & Products

Online Slot Games
Table and Live Dealer Games
Bonuses and Promotions
Mobile-Optimized Gaming
Secure Payment Processing

Target Customers

Australian Gamblers Global Online Casino Players Cryptocurrency Users Mobile Gaming Enthusiasts Loyalty Program Participants

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed $7.00M 2
Refactor Capital Alexandria Venture Investments
Refactor Capital, Alexandria Venture Investments
01 Jan 2023
Seed $6.00M 6
AME Cloud Ventures Third Kind Venture Capital Refactor Capital
AME Cloud Ventures, Third Kind Venture Capital +4
01 May 2021

Melonfrost Alternatives & Competitors

View All Alternatives
Melonfrost vs
Bioreactors.net
Bioreactors.net Latvia

Innovation driven Tailor made

Seed
8 employees
Biotechnology, Manufacturing
Melonfrost vs
Symbio Robotics
Symbio Robotics United States

Symbio Robotics provides software that makes industrial robots more capable.

Series B
1 employees
AI, Automation
Melonfrost vs
Membio Inc.
Membio Inc. Canada

Scalable single-use bioreactors.

Seed
4 employees
Biotechnology, Health Care
View all alternatives

FAQ About Melonfrost

The Bioreactor Company
Melonfrost was founded in 2019.
Melonfrost is headquartered in Brooklyn, United States.
Melonfrost operates in AI, Biotechnology, Manufacturing and Robotics. Its work centres on biomanufacturing, bioreactors, bioproduct development and R&D streamlining. Its customers include Australian Gamblers, Global Online Casino Players and Cryptocurrency Users.
Melonfrost has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Service Fee and Usage Based.
Melonfrost has approximately 3 employees.
Melonfrost has completed 2 funding rounds, raising a total of $13.00M. The latest funding stage is Seed.
Melonfrost offers: Online Slot Games, Table and Live Dealer Games, Bonuses and Promotions, Mobile-Optimized Gaming, Secure Payment Processing.
Top alternatives and competitors to Melonfrost include Bioreactors.net, Symbio Robotics, Membio Inc., Culture Biosciences, Atmos. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Melonfrost and Bioreactors.net are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Melonfrost, https://bouncewatch.com/company/melonfrost, updated 24 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout